Pharmacokinetics of nanotechnology-based formulations in pediatric populations.

Pharmacokinetics of nanotechnology-based formulations in pediatric populations.
Adv Drug Deliv Rev. 2019 Sep 05;:
Authors: Yellepeddi V, Joseph A, Nance E
Abstract
The development of therapeutics for pediatric use has advanced in the last few decades. However, off-label use of adult medications in pediatrics remains a significant clinical problem. Furthermore, the development of therapeutics for pediatrics is challenged by the lack of pharmacokinetic (PK) data in the pediatric population. To promote the development of therapeutics for pediatrics, the United States Pediatric Formulation Initiative recommended the investigation of nanotechnology-based delivery systems. Therefore, in this review, we provided comprehensive information on the PK of nanotechnology-based formulations from preclinical and clinical studies in pediatrics. Specifically, we discuss the relationship between formulation parameters of nanoformulations and PK of the encapsulated drug in the context of pediatrics. We review nanoformulations that include dendrimers, liposomes, polymeric long-acting injectables (LAIs), nanocrystals, inorganic nanoparticles, polymeric micelles, and protein nanoparticles. In addition, we describe the importance and need of PK modeling and simulation approaches used in predicting PK of nanoformulations for pediatric applications.
PMID: 31494124 [PubMed - as supplied by publisher]

Source: Advanced Drug Delivery Reviews - September 4, 2019 Category: Drugs & Pharmacology Authors: Yellepeddi V, Joseph A, Nance E Tags: Adv Drug Deliv Rev Source Type: research